caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1801864988

Jagmohan KhairaM.D.

Internal MedicineAlameda, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Jagmohan Khaira's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 8 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
BLOOM, ROBERT50236
Harkesh Sandhu
Internal Medicine · Fair Oaks, CA
2553
IXIA HOLDINGS, LLC1830
PATHWAYS HOME HEALTH AND HOSPICE1646
William Lowery
Pulmonary Disease · Alameda, CA
14242
James Yeh
Internal Medicine · Alameda, CA
1263
Robert Deutsch
Pulmonary Disease · Alameda, CA
1277
Charleen Singh
Nurse Practitioner · Roseville, CA
1212
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
823
Unique beneficiaries
—
Total services
2,086
Distinct HCPCS
12
Medicare payment
$170K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — top quintile (cohort median 531).
PRESCRIBING · PART D · 2024
Total Rx claims
3,419
Beneficiaries
—
Total drug cost
$293K
Distinct drugs
81
Brand share
14.9%
Top prescribed drugs
Amlodipine Besylate257 claims
Atorvastatin Calcium255 claims
Losartan Potassium250 claims
Lisinopril213 claims
Metformin Hcl154 claims
QUALITY · MIPS · 2024
Final MIPS score
87.3
Quality
70.8
Cost
86.8
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.52%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$388
Payment records
21
By payment type
Food and Beverage$388